Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Unlocking hidden potential: advancements, approaches, and obstacles in repurposing drugs for cancer therapy
Freya R. Weth, Georgia B. Hoggarth, Anya F. Weth, et al.
British Journal of Cancer (2023) Vol. 130, Iss. 5, pp. 703-715
Open Access | Times Cited: 63

Showing 1-25 of 63 citing articles:

Data Mining and Knowledge Discovery
Akshat Shree Mishra, J. Vijaya
Advances in medical technologies and clinical practice book series (2024), pp. 23-40
Closed Access | Times Cited: 14
Revitalizing Cancer Treatment: Exploring the Role of Drug Repurposing
Rama Rao Malla, V Sathiyapriya, Sree Makena, et al.
Cancers (2024) Vol. 16, Iss. 8, pp. 1463-1463
Open Access | Times Cited: 7
Breakthroughs in AI and Multi-Omics for Cancer Drug Discovery: A Review
Israr Fatima, Abdur Rehman, Yanheng Ding, et al.
European Journal of Medicinal Chemistry (2024) Vol. 280, pp. 116925-116925
Closed Access | Times Cited: 6
Repurposing FDA-approved drugs to target G-quadruplexes in breast cancer
Federica Moraca, Valentina Arciuolo, Simona Marzano, et al.
European Journal of Medicinal Chemistry (2025) Vol. 285, pp. 117245-117245
Closed Access
An ensemble machine learning-based performance evaluation identifies top In-Silico pathogenicity prediction methods that best classify driver mutations in cancer
Subrata Das, Vatsal Patel, Shouvik Chakravarty, et al.
BioData Mining (2025) Vol. 18, Iss. 1
Open Access
ADAR1 Regulates Lipid Remodeling through MDM2 to Dictate Ferroptosis Sensitivity
Che-Pei Kung, Nick D. Terzich, Ma Xenia G. Ilagen, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Closed Access
Multifunctional Copper (I) Oxide Nanoparticles: Photocatalytic Degradation of Tetracycline, Antibacterial, and Anticancer Activities
Soumen Rakshit, Tamanna Roy, Angshuman Jana, et al.
ChemistrySelect (2025) Vol. 10, Iss. 4
Closed Access
Advantages, Challenges, and Impact of Drug Repurposing for Cancer Treatment
Rabia Zafar, Iqra Safdar, Aiman Munir, et al.
IntechOpen eBooks (2025)
Closed Access
Sustainable Practices in Modern Pharmaceuticals: Eco-design and Green Methodologies
Abhiruj Navabhatra
(2025), pp. 51-85
Closed Access
Tumor-Associated Extracellular Matrix Obstacles for CAR-T Cell Therapy: Approaches to Overcoming
Ilya Klabukov, Alexander E. Kabakov, A. O. Yakimova, et al.
Current Oncology (2025) Vol. 32, Iss. 2, pp. 79-79
Open Access
Drug Repurposing of Voglibose, a Diabetes Medication for Skin Health
Hyeonmi Kim, Chang‐Gu Hyun
Pharmaceuticals (2025) Vol. 18, Iss. 2, pp. 224-224
Open Access
A new era of psoriasis treatment: Drug repurposing through the lens of nanotechnology and machine learning
M Taha Tarek, Riham I. El-Gogary, Amany O. Kamel
International Journal of Pharmaceutics (2025), pp. 125385-125385
Closed Access
Synthesis and application of diazenyl sulfonamide-based schiff bases as potential BRCA2 active inhibitors against MCF-7 breast cancer cell line
Olia Rezaeianzadeh, Sakineh Asghari, Mahmood Tajbakhsh, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Drug Repurposing in Pancreatic Cancer: A Multi-Stakeholder Perspective to Improve Treatment Options for Pancreatic Cancer Patients
Eric W. Hewitt, Gauthier Bouche, Alexandre Alencar, et al.
Cancer Management and Research (2025) Vol. Volume 17, pp. 429-440
Open Access
Old drugs, new challenges: reassigning drugs for cancer therapies
Paulina Czechowicz, Anna Więch-Walów, Jakub Sławski, et al.
Cellular & Molecular Biology Letters (2025) Vol. 30, Iss. 1
Open Access
Antineoplastics for treating Alzheimer's disease and dementia: Evidence from preclinical and observational studies
Viswanath Das, John H. Miller, Alladi Charanraj Goud, et al.
Medicinal Research Reviews (2024) Vol. 44, Iss. 5, pp. 2078-2111
Open Access | Times Cited: 4
Artificial intelligence for drug repurposing against infectious diseases
Anuradha Singh
Artificial Intelligence Chemistry (2024) Vol. 2, Iss. 2, pp. 100071-100071
Open Access | Times Cited: 4
Special Issue: “Drug Repurposing for Cancer Therapies”
Cristina P. R. Xavier, Andreia Palmeira
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 2, pp. 1092-1092
Open Access | Times Cited: 3
Repurposing of SARS-CoV-2 compounds against Marburg Virus using MD simulation, mm/GBSA, PCA analysis, and free energy landscape
Sanjay Kumar, Rajni Dubey, Richa Mishra, et al.
Journal of Biomolecular Structure and Dynamics (2024), pp. 1-20
Closed Access | Times Cited: 3
Drug-Drug Interactions and Synergy: From Pharmacological Models to Clinical Application
Luigino Calzetta, Clive P. Page, Maria Gabriella Matera, et al.
Pharmacological Reviews (2024) Vol. 76, Iss. 6, pp. 1159-1220
Closed Access | Times Cited: 3
Isoorientin: Unveiling the hidden flavonoid's promise in combating cancer development and progression – A comprehensive review
Lucas Fornari Laurindo, Karina Torres Pomini, Enzo Pereira de Lima, et al.
Life Sciences (2024), pp. 123280-123280
Open Access | Times Cited: 3
Developing theragnostics for Alzheimer's disease: Insights from cancer treatment
Hyunju Lee, Hee-Jeong Choi, Yoo Joo Jeong, et al.
International Journal of Biological Macromolecules (2024) Vol. 269, pp. 131925-131925
Open Access | Times Cited: 2
Reverse repurposing: Potential utility of cancer drugs in nonmalignant illnesses
Mina Nikanjam, Kaitlyn Wells, Shumei Kato, et al.
Med (2024) Vol. 5, Iss. 7, pp. 689-717
Closed Access | Times Cited: 2
The combination therapy using tyrosine kinase receptors inhibitors and repurposed drugs to target patient-derived glioblastoma stem cells
Małgorzata Kucińska, Julia Pospieszna, Jing Tang, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 176, pp. 116892-116892
Open Access | Times Cited: 2
Positive Inotropic Agents in Cancer Therapy: Exploring Potential Anti-Tumor Effects
Eduarda Ribeiro, Nuno Vale
Targets (2024) Vol. 2, Iss. 2, pp. 137-156
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top